Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer

Mikah P, Krabbe LM, Eminaga O, Herrmann E, Papavassilis P, Hinkelammert R, Semjonow A, Schrader AJ, Boegemann M

Research article (journal) | Peer reviewed

Details about the publication

JournalBMC Cancer
Volume16
StatusPublished
Release year2016
Language in which the publication is writtenEnglish

Authors from the University of Münster

Bögemann, Martin
Clinic for Urology
Herrmann, Edwin
Clinic for Urology
Hinkelammert, Reemt
Clinic for Urology
Papavassilis, Philipp
Clinic for Urology
Schrader, Andres Jan
Clinic for Urology
Semjonow, Axel
Clinic for Urology